Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Discover methods to keep discipline in updated budgets, such as setting recurring reviews and reinforcing goals after changes.
20,110 articlesA single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...
Chevron reported a year-over-year drop in earnings, even as production rose. This article breaks down why, what it me...
Market rallies can mask drift in your asset mix. Learn why right now is a great moment to rebalance and how to do it ...
Investors weigh SpaceX’s long-term potential as AI-driven data services and satellite connectivity could unlock a mul...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
Investors are scanning cannabis names for growth and resilience. Here are three clear reasons why Green Thumb Industr...
Micron's strategy will face a sweeping test as two giants in the memory market push forward with enormous spending. T...
RF Industries sits at the intersection of connectivity and specialty manufacturing. This guide breaks down what to e...
As Boyd Gaming nears its July 23 earnings, traders are weighing a potential 17.2% upside fueled by a disciplined buyb...
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
Krispy Kreme’s stock jumped after a quarterly report showed potential signs of a turnaround, even as revenue declined...